Modality.AI

Modality.AI is an AI application that has developed an automated, clinically validated system to assess neurological and psychiatric states both in clinic and remotely. The platform utilizes conversational AI to monitor conditions accurately and consistently, allowing researchers and clinicians to review data in near real-time and monitor treatment response over time. Modality.AI collaborates with world-class AI/Machine Learning experts and leading institutions to provide a HIPAA-compliant system for assessing various indications such as ALS, Parkinson's, depression, autism, Huntington's Disease, schizophrenia, and mild cognitive impairment. The platform enables convenient monitoring at home through streaming and analysis of speech and facial responses, without the need for special software or apps. Modality.AI is accessible on various devices with a browser, webcam, and microphone, offering a new approach to efficient and cost-effective clinical trials.

DeepScribe is an AI medical scribe application that leverages advanced speech recognition technology to capture clinical conversations with extreme accuracy. It empowers clinicians and health systems with real-time AI insights, offers customization options to match provider workflows, and ensures trust and safety through features that promote AI transparency. DeepScribe is designed to save time, improve accuracy, drive adoption, and maximize revenue for doctors, hospitals, and health systems. The application is built for enterprise use, allowing users to unlock the power of AI and modernize their patient data strategy.

Beacon Biosignals provides an EEG neurobiomarker platform that is designed to accelerate clinical trials and enable new treatments for patients with neurological and psychiatric diseases. Their platform is powered by machine learning and a world-class clinico-EEG database, which allows them to analyze existing EEG data for insights into mechanisms, PK/PD, and patient stratification. This information can be used to guide further development efforts, optimize clinical trials, and enhance understanding of treatment efficacy.

Binah.ai is an AI-powered Health Data Platform that offers a software solution for video-based vital signs monitoring. The platform enables users to measure various health and wellness indicators using a smartphone, tablet, or laptop. It provides support for continuous monitoring through a raw PPG signal from external sensors and offers a range of features such as blood pressure monitoring, heart rate variability, oxygen saturation, and more. Binah.ai aims to make health data more accessible for better care at lower costs by leveraging AI and deep learning algorithms.

Confident AI is an open-source evaluation infrastructure for Large Language Models (LLMs). It provides a centralized platform to judge LLM applications, ensuring substantial benefits and addressing any weaknesses in LLM implementation. With Confident AI, companies can define ground truths to ensure their LLM is behaving as expected, evaluate performance against expected outputs to pinpoint areas for iterations, and utilize advanced diff tracking to guide towards the optimal LLM stack. The platform offers comprehensive analytics to identify areas of focus and features such as A/B testing, evaluation, output classification, reporting dashboard, dataset generation, and detailed monitoring to help productionize LLMs with confidence.

AnswerTime is an AI-led research tool that leverages artificial intelligence to provide quick and accurate answers to a wide range of research questions. The platform is designed to assist users in finding relevant information efficiently, saving time and effort in the research process. AnswerTime utilizes advanced algorithms to analyze and process data from various sources, delivering reliable results in a matter of seconds. With its user-friendly interface and powerful AI capabilities, AnswerTime is a valuable tool for students, professionals, and researchers seeking to enhance their research productivity.

Athina AI is a comprehensive platform designed to monitor, debug, analyze, and improve the performance of Large Language Models (LLMs) in production environments. It provides a suite of tools and features that enable users to detect and fix hallucinations, evaluate output quality, analyze usage patterns, and optimize prompt management. Athina AI supports integration with various LLMs and offers a range of evaluation metrics, including context relevancy, harmfulness, summarization accuracy, and custom evaluations. It also provides a self-hosted solution for complete privacy and control, a GraphQL API for programmatic access to logs and evaluations, and support for multiple users and teams. Athina AI's mission is to empower organizations to harness the full potential of LLMs by ensuring their reliability, accuracy, and alignment with business objectives.

Trially AI is a HIPAA-compliant AI clinical trial platform that leverages advanced technology to help life science leaders enroll qualified patients faster. The platform uses AI algorithms to unlock rich medical data, match patients to trials, and improve enrollment rates. Trially AI is proven to deliver superior results 4x faster than other technology providers, with features like multiplying enrollment, reducing screen fails, and increasing eligibility accuracy. It benefits sponsors, CROs, research sites, and hospitals by improving enrollment rates, saving time on chart reviews, and enhancing site success outcomes.

Personno.ai is an AI-driven market research platform that provides businesses with access to a pool of AI-generated respondents. These respondents are designed to mimic the behavior and characteristics of real human respondents, allowing businesses to conduct research studies quickly and cost-effectively. Personno.ai's platform includes a range of features that make it easy to create and manage research studies, including the ability to create custom audiences, conduct real-time interviews, and collect both qualitative and quantitative data.

Plat.AI is an automated predictive analytics software that offers model building solutions for various industries such as finance, insurance, and marketing. It provides a real-time decision-making engine that allows users to build and maintain AI models without any coding experience. The platform offers features like automated model building, data preprocessing tools, codeless modeling, and personalized approach to data analysis. Plat.AI aims to make predictive analytics easy and accessible for users of all experience levels, ensuring transparency, security, and compliance in decision-making processes.

Proscia is a leading provider of digital pathology solutions for the modern laboratory. Its flagship product, Concentriq, is an enterprise pathology platform that enables anatomic pathology laboratories to achieve 100% digitization and deliver faster, more precise results. Proscia also offers a range of AI applications that can be used to automate tasks, improve diagnostic accuracy, and accelerate research. The company's mission is to perfect cancer diagnosis with intelligent software that changes the way the world practices pathology.

MedoSync is an AI-driven health platform that empowers users to monitor and analyze their vital and medical data, leveraging AI to provide personalized insights and recommendations for a healthier life. Users can upload lab results, digitize medical documents, use an AI symptom checker, create accounts for family members, and integrate with their healthcare system. The platform offers easy data export, accuracy in health insights, and personalized health recommendations, with a high user satisfaction rate.

Flutch is a platform that specializes in custom AI agent development for various tasks. It offers AI agents support with measurable effects, from proof of concept to production. The platform provides integrations with systems and knowledge bases, full analytics, and quality control. Users can manage agents without the need for developers, enabling them to configure prompts, connect knowledge bases, and configure logic through an intuitive web interface. Flutch emphasizes cost control, security, and transparent management of AI agents, ensuring data security and control. The platform also offers a custom agent development service for unique business processes, including business process analysis, AI strategy, integration with systems, team training, and support.

4Quant is an AI-powered medical imaging platform that utilizes Big Data and Deep Learning technology to accelerate the extraction of high-quality medical labels. The platform offers a range of tools for image analysis, annotation, and data analytics in the medical field. 4Quant aims to provide scalable solutions for medical imaging analysis, statistical reporting, and personalized training in image analysis. The platform is built on the latest Big Data framework, Apache Spark, and integrates with cloud computing for efficient processing of large datasets.

Dimensions AI is an advanced scientific research database that provides a suite of research applications and time-saving solutions for intelligent discovery and faster insight. It hosts the largest collection of interconnected global research data, including publications, clinical trials, patents, policy documents, grants, datasets, and online citations. The platform offers easy-to-understand visualizations, purpose-built applications, and integrated AI technology to speed up research interpretation and analysis. Dimensions is designed to propel research by connecting the dots across the research ecosystem and saving researchers hours of time.

Instabase is an AI-native unstructured data platform that helps businesses transform their processes stuck in unstructured data. It offers solutions for automating document processing workflows, analyzing data from any document or knowledge base, and surfacing insights across all company data. Instabase leverages generative AI, agentic reasoning, and federated processing to enable users to automate processes, find information, and make smarter decisions faster. The platform prioritizes AI privacy, security, and trust, providing users with complete control over their data and enterprise-grade security measures. Instabase has received several awards and recognitions for its innovative approach to leveraging AI for business solutions.

Modality.AI is an AI application that has developed an automated, clinically validated system to assess neurological and psychiatric states both in clinic and remotely. The platform utilizes conversational AI to monitor conditions accurately and consistently, allowing researchers and clinicians to review data in near real-time and monitor treatment response over time. Modality.AI collaborates with world-class AI/Machine Learning experts and leading institutions to provide a HIPAA-compliant system for assessing various indications such as ALS, Parkinson's, depression, autism, Huntington's Disease, schizophrenia, and mild cognitive impairment. The platform enables convenient monitoring at home through streaming and analysis of speech and facial responses, without the need for special software or apps. Modality.AI is accessible on various devices with a browser, webcam, and microphone, offering a new approach to efficient and cost-effective clinical trials.

CEBRA is a self-supervised learning algorithm designed for obtaining interpretable embeddings of high-dimensional recordings using auxiliary variables. It excels in compressing time series data to reveal hidden structures, particularly in behavioral and neural data. The algorithm can decode neural activity, reconstruct viewed videos, decode trajectories, and determine position during navigation. CEBRA is a valuable tool for joint behavioral and neural analysis, providing consistent and high-performance latent spaces for hypothesis testing and label-free applications across various datasets and species.

Mind-Video is an AI tool that focuses on high-quality video reconstruction from brain activity data. It bridges the gap between image and video brain decoding by utilizing masked brain modeling, multimodal contrastive learning, spatiotemporal attention, and co-training with an augmented Stable Diffusion model. The tool aims to recover accurate semantic information from fMRI signals, enabling the generation of realistic videos based on brain activities.

Boff.ai is an AI tool that connects professionals with academia to unlock opportunities and funding for research and development teams. It helps users ask specific questions across various topics and sources replies from experts in the field. The platform ensures privacy and focuses on solutions required, making it a trusted resource for 30,000 academics and R&D professionals.

Modality.AI is an AI application that has developed an automated, clinically validated system to assess neurological and psychiatric states both in clinic and remotely. The platform utilizes conversational AI to monitor conditions accurately and consistently, allowing researchers and clinicians to review data in near real-time and monitor treatment response over time. Modality.AI collaborates with world-class AI/Machine Learning experts and leading institutions to provide a HIPAA-compliant system for assessing various indications such as ALS, Parkinson's, depression, autism, Huntington's Disease, schizophrenia, and mild cognitive impairment. The platform enables convenient monitoring at home through streaming and analysis of speech and facial responses, without the need for special software or apps. Modality.AI is accessible on various devices with a browser, webcam, and microphone, offering a new approach to efficient and cost-effective clinical trials.

Neuralink is a pioneering brain-computer interface (BCI) application that aims to redefine human capabilities by creating a generalized brain interface to restore autonomy to individuals with unmet medical needs. The application focuses on developing fully implantable BCIs that allow users, particularly those with quadriplegia, to control computers and mobile devices using their thoughts. Neuralink's innovative technology includes advanced chips, biocompatible enclosures, and surgical robots for precise implantation. The application prioritizes safety, accessibility, and reliability in its engineering process, with future goals of restoring vision, motor function, and speech capabilities.

Ascenscia is a specialized AI voice assistant designed to streamline lab digitization processes. It integrates with laboratory software and machines to enable hands-free interactions, automating data collection, optimizing workflows, and accelerating R&D cycles. Ascenscia offers features such as data accessibility, data capturing, inventory access, and additional task management. The application is designed for scientific labs, addressing concerns with precision, safety, and adaptability. It boasts high accuracy in understanding scientific terminologies, end-to-end data encryption, multi-lingual support, and customization options for different lab workflows.

HUAWEI Cloud Pangu is an AI tool designed for accelerating drug discovery by optimizing drug molecules. It offers features such as Molecule Search, Molecule Optimizer, and Pocket Molecule Design. Users can submit molecules for optimization and view historical optimization results. The tool is based on the MindSpore framework and has been visited over 300,000 times since August 23, 2021.

Nucleai is an AI-driven spatial biomarker analysis tool that leverages military intelligence-grade geospatial AI methods to analyze complex cellular interactions in a patient's biopsy. The platform offers a first-of-its-kind multimodal solution by ingesting images from various modalities and delivering actionable insights to optimize biomarker scoring, predict response to therapy, and revolutionize disease diagnosis and treatment.

Exscientia is a technology-driven drug design and development company that combines precision design with integrated experimentation to create more effective medicines for patients faster. They operate at the interfaces of human ingenuity, artificial intelligence (AI), automation, and physical engineering, pioneering the use of AI in drug discovery. Exscientia aims to change the underlying economics of drug discovery by rapidly advancing the best scientific ideas into medicines for patients.

Paige is a leading AI company revolutionizing pathology with next-generation technology. They provide diagnostic and biomarker AI, predictive analytics technology, and AI-assisted applications to support cancer detection, subtyping, and molecular biomarker discovery from tissue samples. Paige offers a range of AI suites for prostate, breast, colon, and PanCancer, as well as the innovative Paige Alba™ multi-modal co-pilot. Their advanced AI technology and services help streamline AI development, optimize existing applications, and drive groundbreaking advancements in cancer care.

Undermind is an AI-powered scientific research assistant that revolutionizes the way researchers access and analyze academic papers. By utilizing intelligent language models, Undermind reads and synthesizes information from hundreds of papers to provide accurate and comprehensive results. Researchers can describe their queries in natural language, and Undermind assists in finding relevant papers, brainstorming questions, and discovering crucial insights. Trusted by researchers across various fields, Undermind offers a unique approach to literature search, surpassing traditional search engines in accuracy and efficiency.

Salt AI is a development engine tailored for life sciences organizations, aiming to accelerate advancements in the field by enabling faster adoption and utilization of AI technologies. The platform offers reliable and reproducible AI processes, optimized for speed and efficiency, and promotes transparency and collaboration within workflows. With a focus on supporting best-in-class life sciences research models, Salt AI empowers users to enhance their understanding of biological processes through flexible and performant AI solutions.

VantAI is an AI application focused on generative AI-enabled drug discovery. Their mission is to unlock a new chapter in medicine by making protein interactions programmable. They have an integrated discovery platform with phase-shifting technologies designed to unlock the full potential of the proximity modulator modality. VantAI collaborates with industry leaders to build the future of therapeutic design. The company has launched Neo-1, the first AI model to rewire molecular interactions by unifying structure prediction and generation.

QuantNexus is an applied research collective that pioneers the future of molecular discovery through intelligent automation. Their mission is to empower the next generation of scientists by creating a human and AI partnership that advances biology significantly. The platform, NovoQuantNexus, fuses machine intelligence with human creativity to achieve breakthroughs in record time, outpacing conventional methods and pure-AI approaches. Researchers in pharma, biotech, and academia are leveraging this technology to accelerate discovery and redefine possibilities in life sciences.

PhysioNet is a research resource for complex physiologic signals that facilitates finding, sharing, and reusing health data. It provides access to various datasets and software tools for researchers in the medical field. PhysioNet aims to support the responsible use of data, including guidelines for creating datasets and models from sources like MIMIC. The platform also addresses access restrictions under the DOJ Data Security Program, ensuring compliance with legal obligations while supporting researchers in understanding and navigating policy changes.

Unlearn.ai is an AI-driven platform that specializes in streamlining clinical trials through the use of AI-generated digital twins of patients. By leveraging digital twin technology and disease-specific ML models, Unlearn.ai enables researchers to design and run more efficient and impactful clinical trials across various therapeutic areas. The platform offers solutions to accelerate trial timelines, facilitate faster decision-making, and optimize trial design, ultimately enhancing trial efficiency, insights, and impact.

Eight Sleep is an intelligent bed cooling system that offers exceptional sleep experiences by actively adjusting temperature, elevating the body, and playing integrated soundscapes to improve sleep quality. The Pod works with any mattress to enhance sleep based on individual sleep stages, biometrics, and environment. It provides fully immersive cooling and heating comfort, elevation through an intelligent adjustable base, and integrated surround sound for a personalized sleep environment. The application is clinically proven to deliver real results, including faster sleep onset, more deep sleep, reduced snoring, and fewer night wake-ups. Backed by industry leaders and over 50 clinical studies, Eight Sleep is committed to optimizing rest for peak health and performance.

Woebot Health is a chat-based AI wellness tool that aims to make mental health support radically accessible. Founded in 2017 by clinical research psychologist Dr. Alison Darcy, Woebot Health focuses on providing empathetic and rigorous mental health care through supportive relationships. The tool offers personalized services to improve mental health outcomes and is designed to adapt to the changing needs of individuals and organizations.

Suki AI is an AI-powered healthcare assistant that offers ambient documentation, clinical reasoning, assisted coding, and compliance solutions for clinicians. It provides a robust SDK and suite of APIs for integrating AI capabilities into healthcare applications. Suki aims to reduce the burden of documentation, allowing clinicians to focus on patient care. The platform is fully integrated with major enterprise EHR systems and ensures safe, clinician-reviewed documentation. Suki has a high adoption rate and delivers proven ROI by increasing coding accuracy and clinician efficiency.

PMcardio is an AI-powered platform that offers accurate and rapid diagnosis of cardiovascular diseases through ECG interpretation. It provides healthcare professionals with advanced AI technology to detect conditions such as acute ST-elevation myocardial infarction (STEMI) and reduced Left Ventricular Ejection Fraction (LVEF) within seconds. PMcardio aims to streamline clinical decision-making, enhance diagnostic accuracy, and improve patient care by leveraging AI algorithms trained on millions of patient outcomes. The platform is designed to ensure standardized ECG reports, facilitate care coordination, and meet the highest standards of quality and security in healthcare settings.

Glass Health is an AI-powered clinical decision support platform that empowers clinicians by providing tools to develop differential diagnoses and draft clinical plans. The platform combines cutting-edge AI technology with evidence-based medical knowledge to streamline diagnostic decisions and optimize clinician workflows. Glass Health's mission is to leverage technology to enhance the practice of medicine, increase diagnostic accuracy, implement evidence-based medicine, promote health equity, and improve patient outcomes globally. The platform is built by clinicians, for clinicians, with a deep commitment to safety, ethics, and alignment.

Tempus is an AI-enabled precision medicine company that brings the power of data and artificial intelligence to healthcare. With the power of AI, Tempus accelerates the discovery of novel targets, predicts the effectiveness of treatments, identifies potentially life-saving clinical trials, and diagnoses multiple diseases earlier. Tempus's innovative technology includes ONE, an AI-enabled clinical assistant; NEXT, a tool to identify and close gaps in care; LENS, a platform to find, access, and analyze multimodal real-world data; and ALGOS, algorithmic models connected to Tempus's assays to provide additional insight.

Oncora Medical is a healthcare technology company that provides software and data solutions to oncologists and cancer centers. Their products are designed to improve patient care, reduce clinician burnout, and accelerate clinical discoveries. Oncora's flagship product, Oncora Patient Care, is a modern, intelligent user interface for oncologists that simplifies workflow, reduces documentation burden, and optimizes treatment decision making. Oncora Analytics is an adaptive visual and backend software platform for regulatory-grade real world data analytics. Oncora Registry is a platform to capture and report quality data, treatment data, and outcomes data in the oncology space.

BenevolentAI is a leader in applying advanced AI to accelerate biopharma drug discovery blending science and technology with a focus on finding solutions for complex diseases. We empower both biopharmaceutical companies and our internal scientists to harness the full potential of data and AI to accelerate the next generation of scientific advances. We have built our AI-enabled drug discovery engine to drive a revolution in drug discovery. The Benevolent Platform™ unlocks the power of a vast biomedical data landscape to provide a multidimensional representation of human biology across all diseases. We believe this approach will improve the probability of clinical success, and help us deliver life-changing treatments to patients – because it matters.